MetaCap

Beta Bionics (BBNX) vs Tactile Systems Technology (TCMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Tactile Systems Technology (TCMD) has outperformed Beta Bionics (BBNX) over the past year, losing 0.4% versus a loss of 57.5%. Beta Bionics is the larger company by market cap ($726.3 million vs $573.5 million), about 1.3 times the size. Tactile Systems Technology converts more of its revenue into profit, with a net margin of 5.8% versus -73.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BBNX-57.48%TCMD-0.39%
+34%-22%-77%
Nov 21, 20251 yearNov 20, 2026
BBNX-43.89%TCMD+46.20%
+86%+8%-70%
Jan 27, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BBNX versus TCMD key metrics
MetricBBNXTCMD
Share price$13.36$25.60
Market cap$726.34M$573.48M
1-day change+0.30%-1.50%
YTD return-56.15%-11.72%
1-year return-57.48%-0.39%
5-year return—+23.85%
P/E ratio (TTM)—24.85
Forward P/E—17.41
EPS (TTM)$-1.83$1.03
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$100.25M$329.52M
Revenue growth (YoY)+53.94%+12.47%
Net income (latest FY)$-73.20M$19.09M
Gross margin55.40%75.91%
Operating margin-71.50%8.89%
Net margin-73.02%5.79%
52-week high$32.71$37.77
52-week low$8.80$20.53
Distance from 52-week high-59.16%-32.22%
Analyst consensusbuystrong_buy
Avg. price target upside+87.87%+41.91%
Average volume1.21M248.63K
Shares outstanding54.37M22.40M
Employees4201,086
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TCMD has outperformed BBNX by 57.1 percentage points over the past year.
  • Tactile Systems Technology is more profitable, keeping 5.8 cents of every revenue dollar as net income versus -73.0 cents for Beta Bionics.
  • Beta Bionics grew revenue faster in its latest fiscal year (+53.94% vs +12.47%).

About Beta Bionics

BBNX stock →

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.

Health Care · Medical/Dental Instruments · 420 employees

About Tactile Systems Technology

TCMD stock →

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.

Health Care · Medical/Dental Instruments · 1,086 employees

BBNX vs TCMD FAQ

Which is bigger, Beta Bionics or Tactile Systems Technology?

Beta Bionics (BBNX) is larger, with a market capitalization of $726.34M compared with $573.48M for Tactile Systems Technology (TCMD).

Which stock has performed better over the past year, BBNX or TCMD?

TCMD returned -0.39% over the past 12 months, compared with -57.48% for BBNX (price return, excluding dividends). Past performance does not predict future results.

Are Beta Bionics and Tactile Systems Technology in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons